Direct measurement of propranolol bioavailability during accumulation to steady-state

British Journal of Clinical Pharmacology
A J WoodD G Shand


1. A high performance liquid chromatographic method for the determination of propranolol in human plasma and blood has been developed and used to confirm that cumulation occurred during chronic oral administration, steady-state being achieved within 48 h of beginning 80 mg of the drug every 8 h. 2. The method was adapted to measure [H3]-propranolol and native drug in the same blood sample and was applied to determine simultaneously the disposition of i.v. ([H3]-propranolol) and orally (non-labelled) administered drug after single oral dose of 80 mg and when steady-state had been established on an 80 mg, 8-hourly regimen. 3. Using this approach it was possible to show that a reduced oral clearance at steady-state was associated with a smaller reduction in systemic (i.v.) clearance and no change in liver blood flow. A direct estimate of bioavailability was also possible and was found to be increased at steady-state compared with a single oral dose. 4. We conclude that the accumulation of propranolol during the attainment of steady-state is due to a reduction in intrinsic clearance, resulting in reduced presystemic hepatic extraction.


Oct 1, 1975·Clinical Pharmacology and Therapeutics·G R Wilkinson, D G Shand
Feb 1, 1976·Journal of Pharmacokinetics and Biopharmaceutics·C F GeorgeC T Dollery
Sep 26, 1973·Journal of Chromatography·E Di SalleP L Morselli
Apr 1, 1973·Journal of Pharmacokinetics and Biopharmaceutics·M RowlandG G Graham
Jan 1, 1970·Clinical Pharmacology and Therapeutics·D G ShandJ A Oates

❮ Previous
Next ❯


Jan 1, 1984·European Journal of Clinical Pharmacology·P DorianV Khouw
May 1, 1980·European Journal of Clinical Pharmacology·D B BarnettS R Nahorski
Jan 1, 1982·European Journal of Clinical Pharmacology·A SomogyiR Gugler
Jan 1, 1987·European Journal of Clinical Pharmacology·R L LalondeD M Mirvis
Apr 1, 1985·European Journal of Drug Metabolism and Pharmacokinetics·J MattilaP Männistö
Jan 1, 1990·Pharmacology & Therapeutics·M Barry, J Feely
Sep 1, 1987·Journal of Affective Disorders·P E Hayes, S C Schulz
Dec 1, 1983·Journal of the American College of Cardiology·H J DuffR L Woosley
Mar 19, 1981·The New England Journal of Medicine·J FeelyA J Wood
Jun 27, 2002·Clinical Pharmacokinetics·William H Frishman, Mamata Alwarshetty
May 17, 1982·Klinische Wochenschrift·H R OchsG Bodem
Jan 1, 1979·Drug Metabolism Reviews·G R Wilkinson
Jan 22, 2013·Expert Opinion on Drug Metabolism & Toxicology·Alfredo Carlo AltamuraSilvio Bareggi
Mar 1, 1990·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·T WalleT E Gaffney
Jan 12, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yanfeng WangMoses S S Chow
Mar 5, 2004·Journal of Veterinary Pharmacology and Therapeutics·P C MillsM S Roberts
Nov 10, 1983·The American Journal of Cardiology·M J Kendall, V A John
Jun 1, 1989·Journal of Clinical Pharmacy and Therapeutics·M J Kendall
Nov 1, 1984·British Journal of Clinical Pharmacology·T WalleT E Gaffney
Nov 1, 1983·British Journal of Clinical Pharmacology·R J HermanA J Wood
Dec 1, 1980·British Journal of Clinical Pharmacology·A J WoodD G Shand
Jul 1, 1988·British Journal of Clinical Pharmacology·R L LalondeI W Wainer
Jun 1, 1986·British Journal of Clinical Pharmacology·D BachD J Edwards
May 1, 1986·British Journal of Clinical Pharmacology·S L BowmanJ A Clements
Sep 1, 1986·British Journal of Clinical Pharmacology·T WalleE C Conradi
Jan 1, 1987·Journal of Clinical Pharmacology·J Dunn
Mar 1, 1989·Journal of Clinical Pharmacology·F KellerG Offermann
Dec 1, 1981·British Journal of Clinical Pharmacology·I W ReimannJ Frölich
Nov 10, 1983·The American Journal of Cardiology·M J Kendall
Dec 5, 2012·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·L FilippiG la Marca
Oct 19, 1988·The American Journal of Cardiology·L A Siddoway
Aug 12, 1998·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A P MansurJ A Ramires
Apr 1, 1980·Biopharmaceutics & Drug Disposition·J J MackichanW J Jusko
Jan 1, 1981·Biopharmaceutics & Drug Disposition·G P MouldV Marks

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.